Skip to main content
Log in

8-amino-9-substituted guanines: Potent purine nucleoside phosphorylase (PNP) inhibitors

  • Antiinflammatory/Antiarthritic Agents
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

A series of 8-amino-9-substituted guanines was synthesized and their activity evaluated against human purine nucleoside phosphorylase (PNP). All compounds were found to be potent inhibitors of human PNP (IC50s: 0.17–126 μM). They were also selectively cytotoxic to MOLT-4 lymphoblasts in the presence of a nontoxic amount (10 μM) of the PNP substrate, 2′-deoxyguanosine (GdR). The most potent of these analogs, 2,8-diamino-1,9-dihydro-9-(2-thienylmethyl)-6H-purin-6-one (8-amino-9-(2-thienyl-methyl)guanine; PD 119,229) has an IC50 of 0.17 μM (Ki=0.067 μM), significantly more potent than the known standard, 8-aminoguanosine (IC50=1.40 μM). Thus it represents the most potent PNP inhibitor known to date when tested without limiting the concentration of inorganic phosphate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. S. Strober, A. Tanay, E. Field, R. T. Hoppe, A. Calin, E. G. Engleman, B. Kotzin, B. W. Brown and H. S. Kaplan,Efficacy of total lymphoid irradiation in intractable rheumatoid arthritis, a double-blind, randomized trial. Annals Intern. Med.102, 441–449 (1985).

    Google Scholar 

  2. J. Karsh, J. H. Klippel, P. H. Plotz, J. L. Decker, D. G. Wright, and M. W. Flye,Lymphapheresis in rheumatoid arthritis, a randomized trial. Arthritis Rheum.24, 867–873 (1981).

    PubMed  Google Scholar 

  3. H. E. Paulus, H. I. Machleder, S. Levine, D. T. Y. Yu and N. S. McDonald,Lymphocyte involvement in reumatoid arthritis. Studies during thoracic duct drainage. Arthritis Rheum.20, 1249–1262 (1977).

    PubMed  Google Scholar 

  4. Progress in Allergy, Ciclosporin, V-38 (Ed. J. F. Borel), Karger, New York 1986.

    Google Scholar 

  5. E. R. Giblett, A. J. Ammann, D. W. Wara, R. Sandman and L. K. Diamond,Nucleoside phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity. Lancet1, 1010–1015 (1975).

    Article  PubMed  Google Scholar 

  6. J. D. Stoeckler, C. Cambor, V. Kuhns, S. H. Chu and R. E. Parks, Jr.,Inhibitors of purine nucleoside phosphorylase, C(8) and C(5′) substitutions. Biochem. Pharmacol.31, 163–171 (1982).

    Article  PubMed  Google Scholar 

  7. J. C. Sircar, M. J. Suto, M. E. Scott, Mi K. Dong and R. B. Gilbertsen,Inhibitors of human purine nucleoside phosphorylase. Synthesis, purine nucleoside phosphorylase inhibition, and T-cell cytotoxicity of 2,5-Diaminothiazolo[5,4-d]pyrimidin-7(6H)-one and 2,5-Diaminothiazolo[4,5-d]pyrimidin-7(6H)-one. Two Thio Isosteres of 8-Aminoguanine. J. Med.Chem.29, 1804–1806 (1986).

    Article  PubMed  Google Scholar 

  8. R. B. Gilbertsen, M. E. Scott, Mi K. Dong, L. M. Kossarek, M. K. Bennett, D. J. Schrier and J. C. Sircar,Preliminary report on 8-amino-9-(2-thienylmethyl)guanine (PD 119, 229), a novel and potent purine nucleoside phosphorylase inhibitor. Agents and Actions21, 272–274 (1987).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sircar, J.C., Kostlan, C.R., Pinter, G.W. et al. 8-amino-9-substituted guanines: Potent purine nucleoside phosphorylase (PNP) inhibitors. Agents and Actions 21, 253–256 (1987). https://doi.org/10.1007/BF01966482

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01966482

Keywords

Navigation